IMU completes submission to Hospital Ethics Committees for HER-Vaxx, page-37

Yeah it's just a long wait time to find out, that and risk is the price to pay for a mega return.

This is more of a take a parcel and hold for the next year and see where we're at and calculate if you want to continue. I don't know why people would sell now, do they know how many years has led up to the next few months. It's like training for the next Olympics and pulling out a week before their event.

It's so hard to predict the chance of getting to market. People would love to do it but we haven't even hit the clinic with our new formula. You could look other companies and see how many made it but that doesn't determine our chances, it's more of a rounded guess.

My advise is to at least buy and hold till mimotopes are announced or better till phase 1 results come in then reassess.